BPC
CSTL icon

Banque Pictet & Cie’s Castle Biosciences CSTL Stock Holding History

Banque Pictet & Cie’s Portfolio CSTL Stock Details CSTL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-166,881
Closed -$3.7M – 311
2024
Q1 		$3.7M Sell
166,881
-15,783
-9% -$343K 0.03% 168
2023
Q4 		$3.94M Sell
182,664
-20,611
-10% -$363K 0.03% 166
2023
Q3 		$3.43M Buy
203,275
+19,472
+11% +$341K 0.04% 171
2023
Q2 		$2.52M Sell
183,803
-6,582
-3% -$133K 0.02% 226
2023
Q1 		$4.33M Sell
190,385
-14,032
-7% -$343K 0.04% 185
2022
Q4 		$4.81M Sell
204,417
-43,301
-17% -$1M 0.05% 188
2022
Q3 		$6.46M Buy
247,718
+95,652
+63% +$2.68M 0.07% 146
2022
Q2 		$3.34K Sell
152,066
-5,626
-4% -$131K 0.03% 216
2022
Q1 		$7.07M Sell
157,692
-1,448
-0.9% -$59.8K 0.05% 161
2021
Q4 		$6.82M Buy
159,140
+133,137
+512% +$6.96M 0.05% 182
2021
Q3 		$1.73M Buy
26,003
+2,953
+13% +$208K 0.02% 215
2021
Q2 		$1.69M Buy
23,050
+1,087
+5% +$71.8K 0.02% 215
2021
Q1 		$1.5M Buy
+21,963
New +$1.65M 0.02% 216

Other funds holding CSTL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
PCM
Portolan Capital Management Boston, Massachusetts $1.88B AUM 115.74% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Banque Pictet & Cie's CSTL Position: Q2 2024 in Review

Banque Pictet & Cie sold out of Castle Biosciences (CSTL) in Q2 2024, closing a stake of 166,881 shares — an estimated $3.7M sold.

Banque Pictet & Cie first reported a position in CSTL in Q1 2021 and held it in 13 quarters. The position peaked at $7.07M in Q1 2022. 159 funds tracked by Wall St. Rank hold CSTL as of Q2 2024.

  • Banque Pictet & Cie reported no remaining Castle Biosciences position as of Q2 2024 after selling out during the quarter.
  • Banque Pictet & Cie sold 166,881 Castle Biosciences shares in Q2 2024, an estimated $3.7M.
  • Banque Pictet & Cie first reported a position in Castle Biosciences in Q1 2021 and held it in 13 quarters.
  • Banque Pictet & Cie's Castle Biosciences position peaked at $7.07M in Q1 2022.
  • 159 funds tracked by Wall St. Rank held Castle Biosciences as of Q2 2024.

Based on Banque Pictet & Cie's 13F filing for Q2 2024, filed 25 Jul 2024.